Clinical practiceThe management of hyperammonemia

被引:0
|
作者
Johannes Häberle
机构
[1] University Children’s Hospital Zurich,Kinderspital Zurich, Division of Metabolism
来源
关键词
Ammonia; Glutamine; Urea cycle; Nitrogen metabolism; Awareness; Neurotoxicity; Cerebral edema;
D O I
暂无
中图分类号
学科分类号
摘要
Hyperammonemia is a life-threatening condition which can affect patients at any age. Elevations of ammonia in plasma indicate its increased production and/or decreased detoxification. The hepatic urea cycle is the main pathway to detoxify ammonia; it can be defective due to an inherited enzyme deficiency or secondary to accumulated toxic metabolites or substrate depletion. Clinical signs and symptoms in hyperammonemia are unspecific but they are mostly neurological. Thus, in any unexplained change in consciousness or in any unexplained encephalopathy, hyperammonemia must be excluded as fast as possible. Any delay in recognition and start of treatment of hyperammonemia may have deleterious consequences for the patient. Treatment largely depends on the underlying cause but is, at least in pediatric patients, mainly aimed at establishing anabolism to avoid endogenous protein breakdown and amino acid imbalances. In addition, pharmacological treatment options exist to improve urea cycle function or to remove nitrogen, but their use depend on the underlying disorder. To improve the prognosis of acute hyperammonemia, an increased awareness of this condition is probably more needed than anything else. Likewise, the immediate start of appropriate therapy is of utmost importance. This review focuses on a better understanding of factors leading to ammonia elevations and on practical aspects related to diagnosis and treatment in order to improve clinical management of hyperammonemia.
引用
收藏
页码:21 / 34
页数:13
相关论文
共 50 条
  • [21] Clinical practiceThe bleeding child. Part I: primary hemostatic disorders
    C. Heleen van Ommen
    Marjolein Peters
    European Journal of Pediatrics, 2012, 171 (1) : 1 - 10
  • [22] HYPERAMMONEMIA IN PEDIATRICS - A CHALLENGE TO CLINICAL CHEMISTS
    BACHMANN, C
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1981, 19 (08): : 579 - 579
  • [23] Hyperammonemia: clinical, therapeutic, and educational aspects
    Senthilkumaran, Subramanian
    Karthikeyan, Nanjundan
    Menezes, Ritesh G.
    Thirumalaikolundusubramanian, Ponniah
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (09): : 1894 - 1894
  • [24] Pathophysiology and Management of Hyperammonemia in Organ Transplant Patients
    Seethapathy, Harish
    Fenves, Andrew Z.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 74 (03) : 390 - 398
  • [25] Diagnosis and Management of Hyperammonemia in Newborns: Is It Still a Challenge?
    Ersoy, Melike
    Salihoglu, Ozgul
    Cetin, Tugce
    IRANIAN JOURNAL OF NEONATOLOGY, 2021, 12 (03) : 40 - 47
  • [26] Erenumab: from scientific evidence to clinical practicethe first Italian real-life data
    Barbanti, Piero
    Aurilia, Cinzia
    Egeo, Gabriella
    Fofi, Luisa
    NEUROLOGICAL SCIENCES, 2019, 40 (Suppl 1) : S177 - S179
  • [27] Genetic background and clinical characteristics of infantile hyperammonemia
    Li, Mengyao
    Chen, Xiang
    Chen, Huiyao
    Hu, Liyuan
    Cao, Yun
    Cheng, Guoqiang
    Wang, Laishuan
    Wu, Bingbing
    Lu, Wei
    Yang, Lin
    Zhou, Wenhao
    TRANSLATIONAL PEDIATRICS, 2023, 12 (05) : 882 - 889
  • [28] Hyperinsulinism Hyperammonemia Syndrome, a Rare Clinical Constellation
    Hussain, Jonathan
    Schlachterman, Alexander
    Kamel, Amir
    Gupte, Anand
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2016, 4 (01):
  • [29] EFFECT OF ARGININE MALATE IN EXPERIMENTAL AND CLINICAL HYPERAMMONEMIA
    SZAM, I
    SZENTNER, J
    VASS, A
    HEGEDUSW.I
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1972, 6 (03) : 260 - &
  • [30] Guidelines for acute management of hyperammonemia in the Middle East region
    Alfadhel, Majid
    Al Mutairi, Fuad
    Makhseed, Nawal
    Al Jasmi, Fatma
    Al-Thihli, Khalid
    Al-Jishi, Emtithal
    AlSayed, Moeenaldeen
    Al-Hassnan, Zuhair N.
    Al-Murshedi, Fathiya
    Haeberle, Johannes
    Ben-Omran, Tawfeg
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 479 - 487